Advertisement
Screener

BioVie Inc. (BIVI) Deferred Tax Assets, Capital Loss Carryforwards

2.1 / 5 stars · 20/47 Roast Me

BioVie Inc. Deferred Tax Assets, Capital Loss Carryforwards

BioVie Inc. (BIVI) had Deferred Tax Assets, Capital Loss Carryforwards of $68.09 million as of 2026-06-30, per its 10-K filed 2026-08-13.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsCapitalLossCarryforwards · last filed 2026-08-13

  • 2026-06-30: Deferred Tax Assets, Capital Loss Carryforwards $68.09M.
  • 2025-06-30: Deferred Tax Assets, Capital Loss Carryforwards $58.32M.
  • 2024-06-30: Deferred Tax Assets, Capital Loss Carryforwards $51.43M.
  • 2023-06-30: Deferred Tax Assets, Capital Loss Carryforwards $48.08M; Deferred Tax Assets, Capital Loss Carryforwards as first filed $4.02M.
Period endDeferred Tax Assets, Capital Loss CarryforwardsDeferred Tax Assets, Capital Loss Carryforwards as first filed
2026-06-30$68.09M
10-K · filed 2026-08-13
2025-06-30$58.32M
10-K · filed 2026-08-13
2024-06-30$51.43M
S-1/A · filed 2026-08-06
2023-06-30$48.08M
10-K · filed 2024-09-30
$4.02M
10-K · filed 2023-08-16
2022-06-30$6.41M
10-K · filed 2023-08-16
2021-06-30$1.45M
10-K · filed 2022-09-27
2020-06-30$2.10M
10-K · filed 2021-08-30
2019-06-30$1.42M
10-K/A · filed 2020-08-07
$1.62M
10-K · filed 2019-09-27
2018-06-30$555.06K
10-K · filed 2019-09-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B
Dare Bioscience, Inc. (DARE)United States$0.011B
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
MUSTANG BIO, INC. (MBIO)United States$0.013B
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14